Suspected Carotid Artery Stenosis:Cost-effectiveness of CT Angiography in Work-up of Patients with Recent TIA or Minor Ischemic Stroke by Tholen, Aletta T. R. et al.
  
 University of Groningen
Suspected Carotid Artery Stenosis
Tholen, Aletta T. R.; de Monye, Cecile; Genders, Tessa S. S.; Buskens, Erik; Dippel, Diederik





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2010
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Tholen, A. T. R., de Monye, C., Genders, T. S. S., Buskens, E., Dippel, D. W. J., van der Lugt, A., &
Hunink, M. G. M. (2010). Suspected Carotid Artery Stenosis: Cost-effectiveness of CT Angiography in
Work-up of Patients with Recent TIA or Minor Ischemic Stroke. RADIOLOGY, 256(2), 585-597.
https://doi.org/10.1148/radiol.10091157
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Note:  This copy is for your personal, non-commercial use only. To order presentation-ready copies for 
distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. 
ORIGINAL RESEARCH n
 NEURORADIOLOGY
Radiology: Volume 256: Number 2—August 2010 n radiology.rsna.org 585
 Suspected Carotid Artery 
Stenosis:  Cost-effectiveness 
of CT Angiography in Work-up 
of Patients with Recent TIA 
or Minor Ischemic Stroke 1 
 Aletta T. R .  Tholen ,  MSc 
 Cécile  de Monyé ,  MD 
 Tessa S. S.  Genders ,  MSc 
 Erik  Buskens ,  MD ,  PhD 
 Diederik W. J.  Dippel ,  MD ,  PhD 
 Aad  van der Lugt ,  MD ,  PhD 
 M. G. Myriam  Hunink ,  MD ,  PhD 
 Purpose: To assess the effectiveness and cost-effectiveness of state-of-
the-art noninvasive diagnostic imaging strategies in patients 
with a transient ischemic attack (TIA) or minor stroke who are 
suspected of having carotid artery stenosis (CAS).
 Materials and 
Methods: 
All prospectively evaluated patients provided informed consent, 
and the local ethics committee approved this study. Diagnostic 
performance, treatment, long-term events, quality of life, and costs 
resulting from strategies employing duplex ultrasonography (US), 
computed tomographic (CT) angiography, contrast material–
enhanced magnetic resonance (MR) angiography, and combina-
tions of these modalities were modeled in a decision tree and 
Markov model. Data sources included a prospective diagnostic 
cohort study, a meta-analysis, and a review of the literature. 
Outcomes were costs, quality-adjusted life-years (QALYs), 
incremental cost-effectiveness ratios, and net health benefi ts 
(QALY-equivalents), with a willingness-to-pay threshold of 
 € 50 000 per QALY and a societal perspective. The strategy with 
the highest net health benefi t was considered the most cost 
effective. Extensive one-way, two-way, and probabilistic sensitivity 
analyses to explore the effect of varying parameter values were 
performed. The reference case analysis assumed that patients 
underwent surgery 2–4 weeks after the fi rst symptoms, and the 
effect of earlier intervention was explored.
 Results: The reference case analysis showed that duplex US combined 
with CT angiography and surgery for 70%–99% stenoses was the 
most cost-effective strategy, with a net health benefi t of 13.587 
and 15.542 QALY-equivalents in men and women, respectively. 
In men, the CT angiography strategy with a 70%–99% cutoff 
yielded slightly more QALYs, at an incremental cost of  € 71 419 
per QALY, compared with duplex US combined with CT angiog-
raphy. In patients with a high-risk profi le, in patients with a high 
prior probability of disease, and when patients could be treated 
within 2 weeks after the fi rst symptoms, the CT angiography 
strategy with surgery for 50%–99% stenoses was the most cost-
effective strategy.
 Conclusion: In diagnosing CAS, duplex US should be the initial test, and, if 
its results are positive, CT angiography should be performed; 
patients with 70%–99% stenoses should then undergo carotid 
endarterectomy. In patients with a high-risk profi le, a high 
probability of CAS, or who can undergo surgery without delay, 
immediate CT angiography and surgery for 50%–99% stenoses 
is indicated.
 q RSNA, 2010
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 Materials and Methods 
 Study Population 
 The target patient population was pa-
tients with a TIA or minor stroke who 
were suspected of having CAS. 
 Decision Model 
 A decision model was developed to 
evaluate and compare various diagnostic 
strategies by using decision-analytical 
software (TreeAge Pro, version 3.5, 2009; 
TreeAge, Williamstown, Mass). We as-
sessed all feasible strategies in normal 
practice, all tests separately, and CT 
angiography or contrast-enhanced MR 
angiography combined with duplex US. 
In the combination strategies, if duplex 
US results appeared positive or uninter-
pretable, a CT angiography or contrast-
enhanced MR angiography examination 
followed. A noninvasive test with un-
interpretable results was followed by a 
DSA examination in single noninvasive 
test strategies and if the results of the 
second test in a combination strategy 
were uninterpretable. We considered 
as to whether alternatives exist that 
overall would yield better outcomes. 
Although this question has been stud-
ied before, results of an analysis of the 
effectiveness and cost-effectiveness of, 
in particular, multidetector computed 
tomographic (CT) angiography alone 
and in comparison to duplex ultra-
sonography (US) and contrast material–
enhanced magnetic resonance (MR) an-
giography have, to our knowledge, not 
yet been published ( 3,7–10 ). 
 The purpose of this study was 
to assess the effectiveness and cost-
effectiveness of state-of-the-art nonin-
vasive diagnostic imaging strategies in 
patients with a TIA or a minor stroke 
who are suspected of having CAS. Par-
ticular attention was paid to the time 
window between the fi rst ischemic symp-
toms and carotid endarterectomy and 
the cutoff value chosen as an indication 
for surgery (70%–99% vs 50%–99% 
stenosis). 
 In 10%–30% of patients with a tran-sient ischemic attack (TIA) or stroke, the cause is a carotid artery stenosis 
(CAS) of 70% or greater ( 1,2 ). Detec-
tion of a CAS is essential to reduce 
the probability of a (recurrent) stroke. 
Carotid endarterectomy reduces the ab-
solute risk of ipsilateral ischemic stroke 
by 18% in patients with 70%–99% 
symptomatic CAS and by 8% in patients 
with a stenosis of 50%–69%, as docu-
mented in the North American Symp-
tomatic Carotid Endarterectomy Trial 
(NASCET) ( 3,4 ).The benefi t of carotid 
endarterectomy, however, depends on 
the delay between the fi rst symptoms 
of ischemia and surgery: The benefi t 
from surgery decreases rapidly with an 
increasing delay ( 5 ). 
 Digital subtraction angiography (DSA) 
remains the reference standard for di-
agnosing a CAS, according to several 
large randomized trials, such as NASCET 
and the European Carotid Surgery Trial 
( 1,4,6 ). Because DSA is both invasive 
and expensive ( 3 ), the question arises 
 Implications for Patient Care 
 Our study results suggest that in  n
patients with a TIA or minor 
stroke, the diagnostic work-up 
should be duplex US as the initial 
diagnostic test; CT angiography 
should then be performed if the 
duplex US results are positive, 
assuming carotid endarterectomy 
is performed 2–4 weeks after 
presentation in patients harbor-
ing stenoses of 70%–99%. 
 Our study suggests that in  n
patients with a high-risk profi le, 
with a high prior probability of 
carotid artery stenosis, or who 
can undergo surgery within 2 
weeks after the initial symptoms, 
immediate CT angiography and 
surgery for stenoses of 50%–99% 
are indicated. 
 The optimal diagnostic strategy  n
depends on the diagnostic tests 
available, local expertise, the 
patient’s sex, the risk profi le 
for recurrent stroke, and the 
time window between the fi rst 
symptoms and carotid 
endarterectomy. 
 Advances in Knowledge 
 The diagnostic performance of  n
multidetector CT angiography is 
high. 
 Multidetector CT angiography  n
alone or combined with duplex 
US is the most cost-effective 
diagnostic test strategy for sus-
pected carotid artery stenosis in 
the work-up of patients with a 
recent transient ischemic attack 
(TIA) or minor ischemic stroke. 
 Patient sex, risk profi le for recur- n
rent stroke, and the time window 
between the fi rst ischemic symp-
toms and carotid endarterectomy 
determine whether CT angiogra-
phy alone versus the combination 
strategy of duplex US and CT 
angiography is the most cost 
effective and which cutoff value 
should be chosen as an indica-
tion for surgery (50%–99% vs 
70%–99% stenosis). 
 In women, the results were less  n
sensitive to changes in the input 
values than in men. 




 CAS = carotid artery stenosis 
 CI = confi dence interval 
 DSA = digital subtraction angiography 
 EVPI = expected value of perfect information 
 HRR = hazard rate ratio 
 ICER = incremental cost-effectiveness ratio 
 NASCET = North American Symptomatic Carotid Endart-
erectomy Trial 
 NHB = net health benefi t 
 QALY = quality-adjusted life-year 
 TIA = transient ischemic attack 
 WTP = willingness-to-pay 
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severe stenosis (50%–69%). To keep 
the input data consistent, we derived 
the prior probability from the same 
study from which we derived the ac-
curacy of CT angiography. Nevertheless, 
we performed sensitivity analysis by 
using a wide range of possible prior 
probabilities to explore the effect of 
this variable on the decision. On av-
erage, male patients were 62 years of 
age and female patients were 61 years 
of age. The age range of the entire 
population was 19–90 years, with an 
average age of 62 years. All patients un-
derwent duplex US and multidetector 
CT angiography of the carotid arteries. 
If one of the examinations showed a 
stenosis of 50%–99%, a DSA exami-
nation of the carotid arteries followed 
in the context of the prospective diag-
nostic cohort study. If neither duplex 
given in Appendix E1 (online) and Fig-
ure E1 (online). 
 Data Sources and Assumptions 
 Prior probability.— The prior probability 
of CAS was based on results of a cross-
sectional prospective diagnostic cohort 
study of 351 patients with a TIA or mi-
nor stroke who were admitted between 
November 2002 and January 2005 to 
Erasmus University Medical Center, 
Rotterdam, the Netherlands. Percent-
age stenosis was categorized by using 
the NASCET method ( 1 ). Data in 194 
male and 139 female patients who had 
a TIA or minor stroke were included 
in the study. Nineteen (9.8%) male pa-
tients and three female patients (2.2%) 
had a severe stenosis (70%–99%), and 
four (2.1%) male patients and two fe-
male patients (1.4%) had a moderately 
two cutoff values for the indication 
for carotid endarterectomy: 70%–99% 
or 50%–99% stenosis. These cutoff 
values were also the positivity crite-
ria used in interpreting test results. 
In combination strategies, we consid-
ered additional strategies by using the 
50%–99% positivity criterion in inter-
preting the duplex US results if the indi-
cation for endarterectomy was 70%–
99%, to maximize sensitivity ( Fig 1 ) . 
Both the advantages and the disad-
vantages of diagnostic tests and of 
treatment with endarterectomy were 
modeled. 
 A Markov model with a 1-year 
cycle length was developed to extrapo-
late and evaluate long-term outcomes 
of diagnostic work-up and subsequent 
treatment. More details about the de-
cision model and Markov model are 
 Figure 1 
  
 Figure 1: Schematic representation of decision tree.   = Decision node,   = chance node,  M = Markov node. After a 
positive result, carotid endarterectomy  (CEA) is performed. DSA has the same structure as a single-test strategy.  Clone = the 
structure of the tree at that point is identical to that of another subtree, which is marked with a black line and a corresponding 
number. Only one combination strategy (duplex US  [DUS] plus CT angiography  [CTA]  ) and one solo strategy (duplex US) have 
been expanded to limit the size of this fi gure. The other strategies have a similar structure, however, when combined with an-
other test.  ∗ = For the other combination strategy, (duplex US plus contrast-enhanced MR angiography  [CE-MRA]  ), the second 
test would be contrast-enhanced MR angiography instead of CT angiography.  FN = false-negative,  FP = false-positive, 
 TN = true-negative,  TP = true-positive. 
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 Table 1 
 Prevalence, Diagnostic Tests, and Procedures: Parameter Estimates, Reported Ranges, and Data Sources 
Parameter Point Estimate * Source
Prevalence of CAS
 0%–49% Stenosis 0.88 (0.84, 0.92) Prospective diagnostic cohort study
  Men 0.84 (0.78, 0.88) Prospective diagnostic cohort study
  Women 0.95 (0.90, 0.98) Prospective diagnostic cohort study
 50%–69% Stenosis 0.02 (0.01, 0.04) Prospective diagnostic cohort study
  Men 0.02 (0.00, 0.05) Prospective diagnostic cohort study
  Women 0.01 (0.00, 0.05) Prospective diagnostic cohort study
 70%–99% Stenosis 0.07 (0.04, 0.10) Prospective diagnostic cohort study
  Men 0.10 (0.06, 0.15) Prospective diagnostic cohort study
  Women 0.02 (0.00, 0.06) Prospective diagnostic cohort study
 100% Stenosis 0.03 (0.02, 0.06) Prospective diagnostic cohort study
  Men 0.05 (0.02, 0.09) Prospective diagnostic cohort study
  Women 0.01 (0.00, 0.05) Prospective diagnostic cohort study
Carotid endarterectomy
 Risk of stroke in men 0.055 (0.015, 0.15) Reference 3
 Risk of stroke in women 0.070 (0.02, 0.26) References 3, 11
 Mortality 0.0106 (0.003, 0.03) Reference 3
 Costs † 4535 (3402, 5669) Cost analysis
 Time cost for patients (min) 4320 (3240, 5400) Cost analysis
Contrast-enhanced MR angiography 
 Sensitivity for 70%–99% stenosis 0.94 (0.88, 0.97) Reference 8
 Specifi city for 70%–99% stenosis 0.93 (0.89, 0.96) Reference 8
 Sensitivity for 50%–99% stenosis 0.96 (0.90, 0.99) Reference 8
 Specifi city for 50%–99% stenosis 0.96 (0.90, 0.99) Reference 8
 Uninterpretable (%) 0.114 (0.09, 0.143) Reference 3
 Mortality due to contrast agent allergy 0.0000007 (0, 0.000016) Reference 12
 Costs † 384 (288, 480) Cost analysis
 Time cost for patients (min) 120 (90, 150) Cost analysis
CT angiography
 Sensitivity for 70%–99% stenosis 0.91 (0.71, 0.99) Prospective diagnostic cohort study
 Specifi city for 70%–99% stenosis 0.99 (0.98, 1.00) Prospective diagnostic cohort study
 Sensitivity for 50%–99% stenosis 1.00 (0.88, 1.00) Prospective diagnostic cohort study
 Specifi city for 50%–99% stenosis 0.98 (0.96, 0.99) Prospective diagnostic cohort study
 Uninterpretable (%) 0.003 (0, 0.02) Prospective diagnostic cohort study
 Mortality due to contrast agent allergy 0.0000007 (0, 0.000016) Reference 12
 Costs † 198 (146, 247) Cost analysis
 Time cost for patients (min) 90 (67.5, 112.5) Cost analysis
DSA
 Sensitivity 1 Assumption
 Specifi city 1 Assumption
 Risk of stroke 0.05 (0.003, 0.008) Reference 13
 Mortality due to contrast agent allergy 0.0000007 (0, 0.000016) Reference 12
 Mortality 0.001 (0.0003, 0.003) Reference 13
 Costs † 906 (680, 1133) Cost analysis
 Time cost for patients (min) 285 (214, 356) Cost analysis
Duplex US
 Sensitivity for 70%–99% stenosis 0.89 (0.85, 0.92) Prospective diagnostic cohort study
 Specifi city for 70%–99% stenosis 0.84 (0.77, 0.89) Prospective diagnostic cohort study
 Sensitivity for 50%–99% stenosis 0.84 (0.62, 0.95) Prospective diagnostic cohort study
 Specifi city for 50%–99% stenosis 0.83 (0.73, 0.90) Prospective diagnostic cohort study
Table 1 (continues)
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opinion and age- and sex-specifi c na-
tional survival statistics. The benefi t of 
surgical treatment as compared with 
medical treatment was calculated. From 
the same national survival statistics, we 
calculated the risk of dying of a noncere-
brovascular accident. 
 Prognosis and patient risk profi le.— 
In addition, we estimated the hazard 
rate ratios (HRRs) for stroke and death 
in patients with high-risk profi les com-
pared with patients with low-risk profi les 
and explored their effect on the decision 
( Table 3 ) ( 20 ). A high-risk profi le was 
defi ned as either unilateral weakness or 
a symptom duration of 60 minutes or 
longer or at least two of the following: 
age 60 years or greater, blood pressure 
140/90 mm Hg or higher, speech impair-
ment without weakness, a symptom du-
ration of 10–59 minutes, and diabetes. 
High risk was associated with an HRR of 
2.0 or greater. Finally, we explored the 
effect of time between fi rst symptoms 
and treatment ( Table 3 ) ( 1,3,5 ). 
 Quality of Life 
 Scores on a utility scale for quality of 
life after a TIA, after a minor stroke, 
and after a major stroke were estimated 
from several published studies ( 3,7,23 ). 
After a TIA or carotid endarterectomy, 
we assumed that patients had a utility 
of 0.88, which is similar to the mean 
utility in the general population of the 
same age ( 26 ). We estimated the utility 
after a minor stroke (0.71) from the 
literature, and we used a utility of 0.31 
for after a major stroke ( Table 3 ) 
( 7,22,23 ). We also included disutilities 
for the events: For a TIA, we used a 
disutility of 0.0017, which we calculated 
in the same way as Buskens et al ( 3 ). 
For a minor or major stroke, we used 
and 0.84 (95% CI: 0.62, 0.95) and 0.83 
(95% CI: 0.73, 0.90) at a cutoff point 
of 50%–99% stenosis ( Table 1 ). The 
sensitivity and specifi city, respectively, 
of contrast-enhanced MR angiography 
were 0.94 (95% CI: 0.88, 0.97) and 
0.93 (95% CI: 0.89, 0.96) at a cutoff 
point of 70%–99% stenosis and 0.96 
(95% CI: 0.90, 0.99) and 0.96 (95% CI: 
0.90, 0.99) at a cutoff point of 50%–
99% stenosis ( Table 1 ). 
 Information on the disadvantages 
of the tests was obtained from the pro-
spective diagnostic cohort study and 
from the literature ( 13,15 ). The percent-
age of uninterpretable test results with 
duplex US was based on fi ndings from 
the prospective diagnostic cohort study 
and was 1.99% (seven of 351 patients). 
Contrast-enhanced MR angiography 
cannot be performed in patients who 
are claustrophobic; this applied to 40 
(11.4%) of 350 patients ( 3 ). Allergy to 
contrast medium confers a very small 
probability of dying (5.9  3 10  2 6 ) ( 12 ), 
which applies to contrast-enhanced MR 
angiography, CT angiography, and DSA. 
DSA as such imposes a risk of inducing 
a major stroke or death; this risk was 
modeled ( Table 1 ) ( 13 ). 
 Treatment results.— According to 
the latest publications on the treat-
ment of CAS, carotid endarterectomy is 
still reported to be the best treatment 
( 16–18 ). Consequently, we modeled ca-
rotid endarterectomy as the treatment 
for CAS. The periprocedural probability 
of stroke was modeled in a sex-specifi c 
fashion ( Table 1 ) ( 11 ). Long-term out-
comes were calculated in the same fash-
ion as in the previous cost-effectiveness 
study by Buskens et al ( 3 ) (Table 2). 
Buskens et al combined published clini-
cal NASCET trial data with expert 
US nor CT angiography showed a steno-
sis of greater than 50%, or if both ex-
aminations showed a stenosis of greater 
than 80%, DSA was not performed, to 
avoid unnecessary risk to the patient. 
Results of duplex US and CT angiogra-
phy were interpreted independently. In 
the model, we used sex-specifi c prior 
probabilities of CAS ( Table 1 ). 
 Diagnostic test performance.— Data 
on the performance of CT angiography 
were derived from the same cross-
sectional study mentioned above. The 
sensitivity and specifi city of CT angiog-
raphy at a cutoff point of 70%–99% 
stenosis were 0.91 (95% CI: 0.71, 
0.99) and 0.99 (95% CI: 0.98, 1.00), 
respectively. Sensitivity and specifi city 
at a cutoff point of 50%–99% stenosis 
were 1.00 (95% CI: 0.88, 1.00) and 0.98 
(95% CI: 0.96, 0.99), respectively. 
 Written informed consent for the 
prospective diagnostic cohort study was 
obtained from all 351 patients, and 
the local ethics committee approved 
the study. 
 The diagnostic performances of du-
plex US and contrast-enhanced MR 
angiography were based on results of a 
meta-analysis ( 8 ) that included 41 studies 
(2541 patients, 4876 arteries) published 
between January 1987 and April 2004. 
All studies included in the meta-analysis 
compared noninvasive imaging with intra-
arterial angiography and met Standards 
for Reporting of Diagnostic Accuracy 
criteria; this ensured that only good-
quality studies were included ( 14 ). Per-
centage stenosis was categorized by 
using the NASCET method ( 4 ). The 
sensitivity and specifi city, respectively, 
of duplex US were 0.89 (95% CI: 0.85, 
0.92) and 0.84 (95% CI: 0.77, 0.89) 
at a cutoff point of 70%–99% stenosis 
Parameter Point Estimate * Source
 Uninterpretable (%) 0.02 (0.008, 0.04) Prospective diagnostic cohort study
 Costs † 42 (32, 53) Cost analysis
 Time cost for patients (min) 80 (60, 100) Cost analysis
* Data in parentheses are 95% confi dence intervals (CIs).
 † All costs were converted to 2007 euros.
Table 1 (continued)
 Prevalence, Diagnostic Tests, and Procedures: Parameter Estimates, Reported Ranges, and Data Sources 
590 radiology.rsna.org n Radiology: Volume 256: Number 2—August 2010
 NEURORADIOLOGY: Cost-effectiveness of CT Angiography in Carotid Artery Stenosis Tholen et al
a disutility of 0.0524—a value we found 
in the literature ( 22 ). 
 Costs 
 We estimated the costs of duplex US, CT 
angiography, and DSA, including hospi-
talization, if applicable, in 2007 euros. 
Current costs, which included expen-
ditures for personnel, equipment, ma-
terials, maintenance, housing, cleaning, 
administration, and overhead, were de-
termined at the Erasmus Medical Center. 
Additional estimates of costs associated 
with hospitalization and stroke in the 
Dutch setting were obtained from the 
study of Buskens et al ( 3 ). For assessment 
of the costs of contrast-enhanced MR an-
giography and carotid endarterectomy, 
we performed a systematic review of 
the published literature ( Table 1 ) ( 27 ). 
 Data Analysis 
 The reference-case analysis was per-
formed for a 60-year-old man. We as-
sumed that the average patient had a 
low-risk profi le and underwent surgery 
between 2 and 4 weeks after the fi rst 
symptoms ( 3,28 ). Diagnostic strategies 
were compared in terms of costs, effects 
(in quality-adjusted life-years [QALYs]), 
incremental cost-effectiveness ratios 
(ICERs), and net health benefi t (NHB) 
by using a threshold willingness-to-pay 
(WTP) of  € 50 000 per QALY. NHB is 
a multiattribute outcome that combines 
effectiveness and costs in one measure, 
with NHB = QALYs  2 (costs/WTP). 
A strategy with the highest NHB was 
considered to be the most cost effec-
tive, which was equivalent to the high-
est QALYs at an ICER of less than the 
WTP of  € 50 000 per QALY. The refer-
ence case analysis was performed by 
using cost estimates and recommenda-
tions for cost-effectiveness analyses from 
the Netherlands that took productivity 
losses (friction costs) into account and 
discounted future costs and effective-
ness at 4% and 1.5%, respectively ( 25 ). 
Also, a second WTP threshold of 
 € 80 000 per QALY was considered, as 
recommended by the Dutch Council for 
Public Health ( 29 ). 
 Subsequently, we performed the 
cost-effectiveness analysis from the 
societal perspective according to United 
 Table 2 
 HRRs and Event Rates: Parameter Estimates and Data Sources 
Parameter Year 0 Year 1 Year 2 Year 3
Long 
Term
HRR of CVA-related mortality after carotid endarterectomy 1.01 1.01 1.01 1.01 1.01
HRR of CVA-related mortality with 100% stenosis 1.175 1.09 1.04 1.03 1.03
HRR of CVA-related mortality with 70%–99% stenosis 1.14 1.07 1.03 1.02 1.02
HRR of CVA-related mortality with 50%–69% stenosis 1.06 1.03 1.015 1.015 1.015
HRR of CVA-related mortality with 0%–49% stenosis 1.02 1.01 1.01 1.01 1.01
Probability of stroke after carotid endarterectomy 0.02 0.02 0.02 0.02 0.02
Probability of stroke with 100% stenosis 0 0 0 0 0
Probability of stroke with 70%–99% stenosis 0.14 0.07 0.03 0.02 0.02
Probability of stroke with 50%–69% stenosis 0.08 0.04 0.02 0.02 0.02
Probability of stroke with 0%–49% stenosis 0.04 0.02 0.02 0.02 0.02
Probability of TIA after carotid endarterectomy 0.01 0.01 0.01 0.01 0.01
Probability of TIA with 100% stenosis 0 0 0 0 0
Probability of TIA with 70%–99% stenosis 0.07 0.04 0.02 0.01 0.01
Probability of TIA with 50%–69% stenosis 0.04 0.02 0.02 0.01 0.01
Probability of TIA with 0%–49% stenosis 0.02 0.01 0.01 0.01 0.01
Note.—Age- and sex-specifi c annual non–cerebrovascular accident (CVA)-related mortality data (in Appendix E1 [online]) were 
obtained from reference 19; all other data were obtained from reference 3.
 Table 3 
 Quality of Life and Costs: Parameter Estimates, Reported Ranges, and Data Sources 
Parameter Point Estimate * Source
HRRs for stroke
 Low- to high-risk profi le 1.0 (1, 10.6) Reference 20
 Early or late treatment after fi rst 
   symptoms
1.0 (0.5, 2.0) Reference 21
Quality-of-life weights
 After TIA 0.88 (0.84, 0.92) References 7, 22, 23 
 After minor stroke 0.71 (0.68, 0.74) Reference 23
 After major stroke 0.31 (0.28, 0.34) Reference 23
 Disutility for TIA 0.0017 (0.0015, 0.0019) Reference 3
 Disutility for minor stroke 0.0524 (0.0523, 0.0525) Reference 22
 Disutility for major stroke 0.0524 (0.0523, 0.0525) Reference 22
Costs † 
 Medication per year 20 (15, 25) Reference 24
 Minor stroke during 1st year 7654 (5740, 9567) Reference 3
 Minor stroke subsequent year 1310 (982, 1637) Reference 3
 Major stroke during 1st year 43 650 (32 737, 54 562) Reference 3
 Major stroke subsequent year 25 487 (19 116, 31 859) Reference 3
 Travel cost per visit 5 (4, 6) Estimation
 Time cost per hour 18 (13, 22) Estimation
 Friction period (wk) 22 Reference 25
 Friction cost per hour
  Men 51 (38, 63) Reference 25
  Women 39 (29, 48) Reference 25
* Data in parentheses are 95% CIs.
 † All costs were converted to 2007 euros
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 Probabilistic Sensitivity Analysis 
 In men, the acceptability curve of the 
combination strategy of duplex US 
and CT angiography with a cutoff of 
70%–99% stenosis was highest (33%–
48%) for all WTP values of less than 
 € 100 000 per QALY ( Fig 3a ). The solo 
CT angiography strategy showed an 
increasing chance of being most cost 
effective with increasing WTP values. 
The value-of-information analysis dem-
onstrated an EVPI for further research 
of  € 318 per male patient, which implies 
of  € 50 000 per QALY, the duplex US–CT 
angiography strategy yielded the highest 
NHB in both men and women, whereas 
with a higher WTP of  € 80 000 per 
QALY, the solo CT angiography strategy 
would be preferable in men ( Table 4 ). 
In both men and women, the least cost-
effective strategy was duplex US per-
formed as a solo test. Furthermore, all 
strategies employing contrast-enhanced 
MR angiography were dominated by the 
corresponding strategies employing CT 
angiography ( Table 4 ). 
States recommendations, considering 
QALYs, health care costs, and direct 
non–health care costs (patient time and 
travel costs), and we discounted both 
future costs and effectiveness at 3% 
 (30–32) . Finally, we performed an anal-
ysis according to United Kingdom rec-
ommendations, discounting both future 
costs and effectiveness at 3.5%  (33,34) . 
 We performed extensive sensitivity 
analyses in which we explored varying 
assumptions about the risk profi le of the 
patient, the timing of surgery after the 
fi rst symptoms, and the prior probabil-
ity of CAS. In addition, we performed a 
probabilistic sensitivity analysis by using 
1000 Monte Carlo simulations in which 
we sampled from distributions of all 
uncertain variable values. We calculated 
the probability that a certain strategy 
was cost effective compared with other 
strategies with varying WTP thresholds 
and present acceptability curves. The 
expected value of perfect information 
(EVPI) (simulation with 1000 samples) 
was calculated to assess the value of 
performing further research ( 35 ). The 
population EVPI was calculated for the 
European Union by assuming an annual 
absolute stroke incidence of 1 million 
among women and 1 million among 
men and considering 5 years ( 36,37 ). 
 Results 
 Reference Case Analysis 
 All strategies that used CT angiography 
or contrast-enhanced MR angiography, 
either as a solo strategy or in combina-
tion with an initial duplex US examina-
tion, demonstrated similar costs and ef-
fectiveness, presuming a 2–4 week delay 
in surgery. In men in similar conditions, 
the combination strategy of duplex US 
followed by CT angiography with a cut-
off of 70%–99% stenosis dominated 
all other strategies, except the solo 
CT angiography strategy with a cutoff 
of 70%–99% stenosis, which yielded 
slightly more QALYs, for  € 71 419 per 
QALY gained ( Fig 2a ,  Table 4 ). Likewise, 
in women, the duplex US–CT angiogra-
phy combination strategy with a cutoff of 
70%–99% stenosis dominated all other 
strategies ( Fig 2b ,  Table 4 ). With a WTP 
 Figure 2 
  
 Figure 2: Cost-effectiveness graphs obtained by using the Dutch recommendations for cost-effectiveness 
analyses in  (a) men and  (b) women show expected lifetime cost versus QALYs for the various strategies.  (a) 
In men, the combination strategy of duplex US  (DUS) and CT angiography  (CTA) with a cutoff of 70%–99% 
stenosis  (70) yielded the highest effectiveness at the lowest costs compared with all other strategies except 
the solo CT angiography strategy with a cutoff of 70%–99% stenosis, which yielded slightly more QALYs, for 
 € 71 419 per QALY gained.  (b) In women, the combination strategy of duplex US and CT angiography with 
a cutoff of 70%–99% stenosis yielded the highest effectiveness at the lowest costs compared with all other 
strategies.  50 = 50%–99% Stenosis,  CE MRA = contrast-enhanced MR angiography. 
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 Patient risk profile.— For men, if 
the HRR for the risk profi le was 1.03, 
indicating a low-risk profi le, the duplex 
US–CT angiography combination strat-
egy with a cutoff of 70%–99% stenosis 
yielded the highest NHB. For HRRs 
that were slightly higher but still close 
to 1.03, the solo CT angiography strat-
egy with a cutoff of 70%–99% stenosis 
was the most cost effective. For HRRs 
patient, which implies a population EVPI 
of  € 193 million for the European Union. 
 Sensitivity Analysis 
 United Kingdom and United States 
recommendations.— Analyses performed 
by using United Kingdom and United 
States recommendations yielded the 
same results as the analysis performed 
by using the Dutch recommendations. 
a population EVPI of  € 1.5 billion for the 
European Union. 
 In women, the acceptability curve 
showed that the duplex US–CT angiogra-
phy combination strategy with a cutoff of 
70%–99% stenosis was most cost effec-
tive, with an 80% probability, irrespective 
of the WTP ( Fig 3b ). The value-of-infor-
mation analysis demonstrated an EVPI 
for further research of  € 40 per female 
 Table 4 
 Reference Case Analysis Results 
Patient and Strategy Costs ( € ) QALYs ICER
NHB for WTP of 
 € 50 000 per QALY
NHB for WTP of 
 € 80 000 per QALY
60-Year-old man
 Duplex US and CT angiography for 70%–99% stenosis 
  (reference strategy)
39 826 14.3832 13.587 13.885
 CT angiography for 70%–99% stenosis 39 893 14.3841  € 71 419 13.586 13.885
 Duplex US and CT angiography for 50%–99% stenosis 39 914 14.3809 Dominated 13.583 13.882
 Duplex US for 50%–99% stenosis and CT angiography for 
  70%–99% stenosis
39 986 14.3787 Dominated 13.579 13.879
 CT angiography for 50%–99% stenosis 40 004 14.3815 Dominated 13.581 13.881
 Duplex US and contrast-enhanced MR angiography for 
  70%–99% stenosis
40 028 14.3799 Dominated 13.579 13.880
 Duplex US and contrast-enhanced MR angiography for 
  50%–99% stenosis
40 162 14.3761 Dominated 13.573 13.874
 Duplex US for 50%–99% stenosis and contrast-enhanced 
  MR angiography for 70%–99% stenosis
40 193 14.3755 Dominated 13.572 13.873
 Contrast-enhanced MR angiography for 50%–99% stenosis 40 924 14.3637 Dominated 13.545 13.852
 Contrast-enhanced MR angiography for 70%–99% stenosis 41 166 14.3562 Dominated 13.533 13.842
 Duplex US for 70%–99% stenosis 41 997 14.3167 Dominated 13.477 13.792
 Duplex US for 50%–99% stenosis 42 368 14.3052 Dominated 13.458 13.776
60-Year-old woman
 Duplex US and CT angiography for 70%–99% stenosis 
  (reference strategy)
45 911 16.4605 15.542 15.887
 Duplex US and CT angiography for 50%–99% stenosis 46 046 16.4562 Dominated 15.535 15.881
 Duplex US for 50%–99% stenosis and CT angiography 
  for 70%–99% stenosis
46 057 16.4559 Dominated 15.535 15.880
 CT angiography for 70%–99% stenosis 46 153 16.4559 Dominated 15.533 15.879
 Duplex US and contrast-enhanced MR angiography for 
  70%–99% stenosis
46 199 16.4531 Dominated 15.529 15.876
 Duplex US and contrast-enhanced MR angiography for 
  50%–99% stenosis
46 256 16.4517 Dominated 15.527 15.873
 Duplex US for 50%–99% stenosis and contrast-enhanced 
  MR angiography for 70%–99% stenosis
46 362 16.4482 Dominated 15.521 15.869
 CT angiography for 50%–99% stenosis 46 475 16.4452 Dominated 15.516 15.864
 Contrast-enhanced MR angiography for 50%–99% stenosis 47 454 16.4239 Dominated 15.475 15.831
 Contrast-enhanced MR angiography for 70%–99% stenosis 47 772 16.4133 Dominated 15.458 15.816
 Duplex US for 70%–99% stenosis 48 965 16.3577 Dominated 15.378 15.746
 Duplex US for 50%–99% stenosis 49 362 16.3448 Dominated 15.358 15.728
Note.—The cost-effectiveness analysis was performed by using recommendations from the Netherlands. Note that all strategies are dominated by the combination strategy of duplex US and CT 
angiography for 70%–99% stenosis (ie, this strategy is more or equally effective and less costly) except for CT angiography of 70%–99% stenosis in men, which had an ICER that was higher than the 
chosen threshold WTP. The percentages refer to the degree of stenosis that was considered a positive test result.
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a cutoff of 70%–99% stenosis had the 
highest NHB when the prior probabil-
ity increased above 0.30; with a lower 
prior probability, the duplex US–CT 
angiography combination strategy with 
a cutoff of 70%–99% stenosis had the 
highest NHB ( Fig 5b ). 
 Timing of surgery.— For men un-
dergoing surgery without delay, the solo 
CT angiography strategy with a cutoff 
of 50%–99% stenosis yielded the high-
est NHB ( Fig 6a ). With a longer delay, 
the solo CT angiography strategy with 
a cutoff of 70%–99% stenosis yielded 
the highest NHB, followed by the duplex 
US–CT angiography combination strat-
egy with a cutoff of 70%–99% stenosis, 
if surgery was performed more than 4 
weeks after fi rst symptoms. For women 
undergoing surgery without delay, the 
duplex US–CT angiography combination 
strategy with a cutoff of 50%–99% 
 Prior probability.— The prior prob-
ability of CAS was derived from the 
prospective diagnostic cohort study and 
was clearly lower than that in the study 
of Buskens et al ( 3 ). For men with a low 
prior probability of disease, the duplex 
US–CT angiography combination strat-
egy with a cutoff of 70%–99% stenosis 
had the highest NHB. When the prior 
probability was greater than 0.20, the 
solo CT angiography strategy had the 
highest NHB, and when the prior prob-
ability was greater than 0.30, CT angiog-
raphy with a cutoff of 50%–99% steno-
sis was optimal ( Fig 5a ). For women, 
the solo CT angiography strategy with 
that were clearly greater than 1.11, the 
CT angiography solo strategy with a 
cutoff for surgery of 50%–99% steno-
sis yielded a higher NHB ( Fig 4 ). For 
women, the duplex US–CT angiogra-
phy combination strategy with a cutoff 
of 70%–99% stenosis was most cost 
effective for an HRR of 1.47 or less; 
above this threshold, the duplex US–
CT angiography combination strategy 
with a cutoff of 50%–99% stenosis had 
a higher NHB. If the HRR was greater 
than 2.34, the solo CT angiography 
strategy with a cutoff of 50%–99% 
stenosis was the most cost effective 
( Fig 4 ). 
 Figure 3 
  
 Figure 3: Acceptability curves with the fi ve most competitive strategies for  (a) 
men and  (b) women. The graphs plot the proportion of simulated scenarios in 
the probabilistic sensitivity analysis for which each of the strategies is the most 
cost effective for varying thresholds of WTP. The probabilistic sensitivity analysis 
included all strategies. Strategies with a very low probability of being cost effec-
tive are not shown.  50 = 50%–99% Stenosis,  70 = 70%–99% stenosis,  CTA = 
CT angiography,  DUS = duplex US. 
 Figure 4 
  
 Figure 4: Graphs show results of sensitivity 
analysis exploring the effect of different patient 
risk profi les in  (a) men and  (b) women. Higher-risk 
profi les are represented with increasing HRRs on 
the x-axis. The outcome is expressed in NHB on the 
y-axis with a WTP of  € 50 000 per QALY. Shading = 
optimal strategy.  50 = 50%–99% Stenosis,  70 = 
70%–99% stenosis,  CTA = CT angiography,  DUS = 
duplex US. 
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though differences are small on average, 
they are nevertheless important be-
cause they pertain to a large group of 
patients and in aggregate can have large 
consequences. Note that a small aver-
age difference in the context of diagnos-
tic test strategies implies that for most 
patients there is no difference between 
the evaluated strategies, but for a few 
patients the consequence can be very 
large in that a serious complication or 
event may be avoided with the optimal 
strategy. 
 In women, results were less sensi-
tive to changes in the input values than 
in men. The probabilistic sensitivity 
analysis demonstrated that whereas for 
women results were fairly robust, re-
sults for men were less certain. The pri-
or probability was lower among women 
and the risk of surgery was higher, im-
plying that the mean expected gain of 
performing a diagnostic work-up is less 
in women; this led to more consistent 
results favoring less invasive imaging 
in the sensitivity analysis. This is also 
refl ected in the results of the value-of-
information analysis, which demonstrated 
a high value, especially in men, which 
suggests that it is worth exploring this 
issue and performing further studies in 
this area, especially for men. 
 As with all decision- and cost-effec-
tiveness models, several assumptions 
had to be made to keep the model co-
herent. In fi nding parameter estimates, 
we chose to stay as close as possible to 
the primary data (especially with respect 
to costs) to ensure the internal consis-
tency of the model, rather than using 
data from diverse published sources. 
This may have reduced the generaliz-
ability of our results. One assumption 
concerned the follow-up period and 
event rates, which were based on the 
article by Buskens et al ( 3 ). Their re-
sults dated from 1998, and since then 
a great deal of new information about 
event rates in the follow-up period has 
been published. We adjusted event rates 
for this new data by including HRRs 
that were found in the literature for the 
patient’s risk profi le and delay between 
fi rst symptoms and surgery. 
 Radiation risk was not considered in 
our model. Although radiation risk is an 
monstrated that with an increase in 
patient risk profi le or with a higher prior 
probability of disease, the criterion to 
perform surgery should be more lenient 
(50%–99% stenosis) and the solo CT 
angiography strategy would be preferred 
to a combination test strategy. Also, 
if surgery can be performed without 
delay, a more lenient criterion (50%–
99%) for surgery and a single-test 
strategy with CT angiography would be 
preferred. Notably, we found that all 
strategies employing contrast-enhanced 
MR angiography were dominated by 
the corresponding CT angiography 
strategies. 
 Although we found very small dif-
ferences in QALYs across the strategies, 
there were clear differences in costs. 
This phenomenon is generally found 
in diagnostic test evaluation ( 38 ). Even 
stenosis had the highest NHB, whereas 
a cutoff of 70%–99% stenosis would be 
best if surgery cannot be performed 
within 2 weeks ( Fig 6b ). 
 Discussion 
 Our study evaluated the cost-effectiveness 
of various noninvasive tests. The results 
demonstrated that the duplex US–CT 
angiography combination strategy with 
a cutoff of 70%–99% stenosis is the 
most cost-effective strategy. If the WTP 
is higher than we assumed—that is, 
 € 80 000 per QALY instead of  € 50 000 
per QALY—then the solo CT angiography 
strategy would be more effective than 
the combination strategy at an accept-
able ICER in men, whereas in women, 
the combination strategy would remain 
optimal. The sensitivity analysis de-
 Figure 5 
  
 Figure 5: Graphs show results of sensitivity analy-
sis exploring the effect of the prior probability of CAS 
(x-axis) on the NHB (y-axis) with a WTP of  € 50 000 
per QALY in  (a) men and  (b) women. Shading = 
corresponding optimal strategy.  50 = 50%–99% 
Stenosis,  70 = 70%–99% stenosis,  CTA = 
CT angiography,  DUS = duplex US. 
 Figure 6 
  
 Figure 6: Graphs show results of sensitivity analy-
sis exploring the effect of a delay in treatment after 
the fi rst symptoms in weeks (x-axis) on the NHB 
(y-axis) with a WTP of  € 50 000 per QALY in 
 (a) men and  (b) women. Shading = corresponding 
optimal strategy.  ∗ ”Short delay’’ = delay in treat-
ment ranging from 2 to 4 weeks; “long delay’’ = 
delay in treatment of more than 4 weeks. 
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Similarly, logistics and waiting lists may 
infl uence the diagnostic work-up. Fur-
thermore, local expertise with duplex 
US, CT angiography, and contrast-
enhanced MR angiography may infl uence 
the decision: If, for example, no local 
expertise exists with CT angiography of 
the carotid arteries, whereas contrast-
enhanced MR angiography can be per-
formed at low cost, without delay, with 
good quality, and with high diagnostic 
performance, then our results justify the 
use of contrast-enhanced MR angiogra-
phy instead of CT angiography. Finally, 
patient behavior, patient preferences, and 
local treatment options should be con-
sidered. Of note, our analysis highlights 
that if patients present rapidly after their 
fi rst symptoms and local treatment of 
patients with TIA or minor stroke is 
streamlined, a solo CT angiography strat-
egy with lenient criteria for surgery is 
indicated. The fact that benefi t can be 
gained by streamlining the work-up of 
patients with TIA or stroke has been 
pointed out before, but as yet, not all 
centers are able to organize TIA and 
stroke care effi ciently ( 5,28 ). 
 In conclusion, patients with a TIA 
or minor stroke should undergo duplex 
US as an initial diagnostic test, fol-
lowed by CT angiography if the duplex 
US results are positive, with surgery 
for 70%–99% stenoses, while in pa-
tients with a high risk profi le, with a 
high prior probability of carotid steno-
sis, or who can undergo surgery with-
out delay, immediate CT angiography 
and surgery for 50%–99% stenoses are 
indicated. 
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